Skip to content
10-Q

Quarterly Report

INTERPACE BIOSCIENCES, INC. IDXG

0001641172-25-022591

← back to feed
Filed
Aug 7, 2025 12:00 AM ET
Period of report
Restated figures. One or more values in this filing restate previously reported amounts.

On SEC.gov

Financials in this filing

Metric Period Value
Shares Outstanding Q2 2025 · Aug 1, 2025 4.42M sh
Shares Diluted Q2 2025 · Jun 30, 2025 4.42M sh
Shares Diluted Q2 2025 · Jun 30, 2025 27.7M sh
Shares Diluted Q2 2025 · Jun 30, 2024 4.4M sh
Shares Diluted Q2 2025 · Jun 30, 2024 4.39M sh
Capex Q2 2025 · Jun 30, 2025 $201K
Capex Q2 2025 · Jun 30, 2024 $225K
Operating Cash Flow Q2 2025 · Jun 30, 2025 $1.76M
Operating Cash Flow Q2 2025 · Jun 30, 2024 $1.35M
Cash And Equivalents Q2 2025 · Jun 30, 2025 $502K
Cash And Equivalents Q2 2025 · Dec 31, 2024 $1.46M
Cash And Equivalents restated Q2 2025 · Jun 30, 2024 $500K
Stockholders Equity Q2 2025 · Jun 30, 2025 −$1.21M
Stockholders Equity Q2 2025 · Mar 31, 2025 −$582K
Stockholders Equity Q2 2025 · Dec 31, 2024 −$2.22M
Stockholders Equity restated Q2 2025 · Jun 30, 2024 −$52.28M
Stockholders Equity restated Q2 2025 · Mar 31, 2024 −$54.77M
Stockholders Equity restated Q2 2025 · Dec 31, 2023 −$55.54M
Current Liabilities Q2 2025 · Jun 30, 2025 $7.15M
Current Liabilities Q2 2025 · Dec 31, 2024 $10.62M
Current Liabilities restated Q2 2025 · Jun 30, 2024 $7.1M
Total Liabilities Q2 2025 · Jun 30, 2025 $13.55M
Total Liabilities Q2 2025 · Dec 31, 2024 $17.01M
Current Assets Q2 2025 · Jun 30, 2025 $9.5M
Current Assets Q2 2025 · Dec 31, 2024 $11.77M
Current Assets restated Q2 2025 · Jun 30, 2024 $9.5M
Total Assets Q2 2025 · Jun 30, 2025 $12.34M
Total Assets Q2 2025 · Dec 31, 2024 $14.79M
Eps Diluted Q2 2025 · Jun 30, 2025 −$0.14
Eps Diluted Q2 2025 · Jun 30, 2025 $0.04
Eps Diluted restated Q2 2025 · Jun 30, 2024 $0.55
Eps Diluted restated Q2 2025 · Jun 30, 2024 $0.72
Eps Basic Q2 2025 · Jun 30, 2025 −$0.14
Eps Basic Q2 2025 · Jun 30, 2025 $0.23
Eps Basic restated Q2 2025 · Jun 30, 2024 $0.56
Eps Basic restated Q2 2025 · Jun 30, 2024 $0.72
Sga Expense Q2 2025 · Jun 30, 2025 $2.66M
Sga Expense Q2 2025 · Jun 30, 2025 $5.21M
Sga Expense Q2 2025 · Jun 30, 2024 $2.14M
Sga Expense Q2 2025 · Jun 30, 2024 $4.38M
Rd Expense Q2 2025 · Jun 30, 2025 $173K
Rd Expense Q2 2025 · Jun 30, 2025 $350K
Rd Expense Q2 2025 · Jun 30, 2024 $146K
Rd Expense Q2 2025 · Jun 30, 2024 $283K
Net Income Q2 2025 · Jun 30, 2025 −$640K
Net Income Q2 2025 · Jun 30, 2025 $1.01M
Net Income Q2 2025 · Mar 31, 2025 $1.65M
Net Income restated Q2 2025 · Jun 30, 2024 $2.44M
Net Income restated Q2 2025 · Jun 30, 2024 $3.15M
Net Income restated Q2 2025 · Mar 31, 2024 $708K
Operating Income Q2 2025 · Jun 30, 2025 −$468K
Operating Income Q2 2025 · Jun 30, 2025 $1.36M
Operating Income restated Q2 2025 · Jun 30, 2024 $2.63M
Operating Income restated Q2 2025 · Jun 30, 2024 $3.75M
Gross Profit Q2 2025 · Jun 30, 2025 $5.28M
Gross Profit Q2 2025 · Jun 30, 2025 $12.65M
Gross Profit restated Q2 2025 · Jun 30, 2024 $7.81M
Gross Profit restated Q2 2025 · Jun 30, 2024 $14.12M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $3.96M
Cost Of Revenue Q2 2025 · Jun 30, 2025 $8.1M
Cost Of Revenue restated Q2 2025 · Jun 30, 2024 $4.24M
Cost Of Revenue restated Q2 2025 · Jun 30, 2024 $8.1M
Revenue Q2 2025 · Jun 30, 2025 $9.23M
Revenue Q2 2025 · Jun 30, 2025 $20.75M
Revenue Q2 2025 · Jun 30, 2024 $12.04M
Revenue restated Q2 2025 · Jun 30, 2024 $22.22M